Array-based genomic screening at diagnosis and during follow-up in chronic lymphocytic leukemia

被引:81
|
作者
Gunnarsson, Rebeqa [1 ,2 ]
Mansouri, Larry
Isaksson, Anders [3 ]
Goransson, Hanna [3 ]
Cahill, Nicola
Jansson, Mattias
Rasmussen, Markus [3 ]
Lundin, Jeanette [4 ,5 ]
Norin, Stefan [4 ]
Buhl, Anne Mette [6 ]
Smedby, Karin Ekstrom [7 ]
Hjalgrim, Henrik [8 ]
Karlsson, Karin [2 ]
Jurlander, Jesper [6 ]
Geisler, Christian [6 ]
Juliusson, Gunnar [2 ]
Rosenquist, Richard
机构
[1] Uppsala Univ, Dept Immunol Genet & Pathol, Rudbeck Lab, SE-75185 Uppsala, Sweden
[2] Lund Univ, Stem Cell Ctr, Dept Lab Med, Lund, Sweden
[3] Uppsala Univ, Dept Med Sci Canc Pharmacol & Informat, SE-75185 Uppsala, Sweden
[4] Karolinska Univ Hosp, Dept Hematol, Stockholm, Sweden
[5] Karolinska Univ Hosp, Dept Oncol, Stockholm, Sweden
[6] Rigshosp, Dept Hematol, Leukemia Lab, DK-2100 Copenhagen, Denmark
[7] Karolinska Inst, Clin Epidemiol Unit, Dept Med, Stockholm, Sweden
[8] Statens Serum Inst, Dept Epidemiol Res, DK-2300 Copenhagen, Denmark
来源
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2011年 / 96卷 / 08期
基金
瑞典研究理事会;
关键词
chronic lymphocytic leukemia; SNP-array; genomic aberrations; CNN-LOH; clonal evolution; CLONAL EVOLUTION; CHROMOSOMAL-ABERRATIONS; DISEASE PROGRESSION; EARLY-STAGE; SNP ARRAYS; DELETION; RISK; SURVIVAL; 13Q14; ABNORMALITIES;
D O I
10.3324/haematol.2010.039768
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background High-resolution genomic microarrays enable simultaneous detection of copy-number aberrations such as the known recurrent aberrations in chronic lymphocytic leukemia [del(11q), del(13q), del(17p) and trisomy 12], and copy-number neutral loss of heterozygosity. Moreover, comparison of genomic profiles from sequential patients' samples allows detection of clonal evolution. Design and Methods We screened samples from 369 patients with newly diagnosed chronic lymphocytic leukemia from a population-based cohort using 250K single nucleotide polymorphism-arrays. Clonal evolution was evaluated in 59 follow-up samples obtained after 5-9 years. Results At diagnosis, copy-number aberrations were identified in 90% of patients; 70% carried known recurrent alterations, including del(13q) (55%), trisomy 12 (10.5%), del(11q) (10%), and del(17p) (4%). Additional recurrent aberrations were detected on chromosomes 2 (1.9%), 4 (1.4%), 8 (1.6%) and 14 (1.6%). Thirteen patients (3.5%) displayed recurrent copy-number neutral loss of heterozygosity on 13q, of whom 11 had concurrent homozygous del(13q). Genomic complexity and large 13q deletions correlated with inferior outcome, while the former was linked to poor-prognostic aberrations. In the follow-up study, clonal evolution developed in 8/24 (33%) patients with unmutated IGHV, and in 4/25 (16%) IGHV-mutated and treated patients. In contrast, untreated patients with mutated IGHV (n=10) did not acquire additional aberrations. The most common secondary event, del(13q), was detected in 6/12 (50%) of all patients with acquired alterations. Interestingly, aberrations on, for example, chromosome 6q, 8p, 9p and 10q developed exclusively in patients with unmutated IGHV. Conclusions Whole-genome screening revealed a high frequency of genomic aberrations in newly diagnosed chronic lymphocytic leukemia. Clonal evolution was associated with other markers of aggressive disease and commonly included the known recurrent aberrations.
引用
收藏
页码:1161 / 1169
页数:9
相关论文
共 50 条
  • [21] EHA Endorsement of ESMO Clinical Practice Guidelines for Diagnosis, Treatment, and Follow-up of Chronic Lymphocytic Leukemia
    Eichhorst, Barbara
    Ghia, Paolo
    [J]. HEMASPHERE, 2021, 5 (01):
  • [22] ARRAY-BASED GENOMIC PROFILING IN CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) IDENTIFIES HIGHER NUMBER OF PROGNOSTIC RELEVANT GENOMIC ALTERATIONS AND REVEALS NEW RECURRENT GENOMIC ABNORMALITIES
    Stevens-Kroef, M.
    van den Berge, E.
    Weghuis, D.
    Dijkhuizen, T.
    Idrissi, N.
    Benjamins, M.
    Linssen-Wiersma, M.
    Siepman, A.
    Groenen, P.
    Simons, A.
    [J]. HAEMATOLOGICA, 2013, 98 : 395 - 396
  • [23] Long-term follow-up and future direction on the management of chronic lymphocytic leukemia/small lymphocytic leukemia
    Hanna, Kirollos S.
    Fijalka, Andrew
    Watson, Ian
    Brown, Olivia
    Ojulu, Apiew
    [J]. JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2022, 28 (08) : 1869 - 1884
  • [24] Changes in Antigen Expression ina Follow-up of Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
    Zhou, Jiehao
    Tewari, Anupama
    Nassiri, Mehdi
    Azar, Jose
    Czader, Magdalena
    [J]. AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2012, 138 : A174 - A174
  • [25] Array-based genomic resequencing of acute myeloid leukemia
    Yamashita, Yoshihiro
    Ueno, Toshihide
    Soda, Manabu
    Mano, Hiroyuki
    [J]. CANCER RESEARCH, 2011, 71
  • [26] Array-based comparative genomic hybridization in clinical diagnosis
    Bajjani, BA
    Theisen, AP
    Ballif, BC
    Shaffer, LG
    [J]. EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2005, 5 (03) : 421 - 429
  • [27] Chronic Myeloid Leukemia: Practical Issues in Diagnosis, Treatment and Follow-Up
    Buyukasik, Yahya
    Haznedaroglu, Ibrahim C.
    Ilhan, Osman
    [J]. UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI, 2010, 20 (02): : 1 - 12
  • [28] Heart transplantation and chronic lymphocytic leukemia: A successful case at 2 years of follow-up
    Manito, N
    Kaplinsky, E
    Roca, J
    de Sevilla, AF
    Castells, E
    Esplugas, E
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2004, 23 (06): : 777 - 779
  • [29] INFECTIONS IN CHRONIC LYMPHOCYTIC-LEUKEMIA - ANALYSIS OF INCIDENCE AS A FUNCTION OF LENGTH OF FOLLOW-UP
    MOLICA, S
    LEVATO, D
    LEVATO, L
    [J]. HAEMATOLOGICA, 1993, 78 (06) : 374 - 377
  • [30] Array-based comparative genomic hybridization identifies deletion at 14q32 as a new prognostic marker in chronic lymphocytic leukemia (CLL).
    Drandi, D
    Lee, C
    Dal Cin, P
    Gribben, JG
    [J]. BLOOD, 2003, 102 (11) : 186A - 186A